TP53 and neoplasm: Additionally, treatment with a VC derivative remarkably suppressed the p53 expression and oxidative damage in the skin of Sod1−/− mice, suggesting that the antioxidant activity of VC normalized the skin pathologies, at least in part, by suppressing O2∙−-mediated p53 activation in vivo [43].